A Study of MT027 in Patients with Pleural Malignant Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of MT027 in Patients with Pleural Malignant Tumors — Stella

Home/Advanced Malignant Solid Tumor/

View on ClinicalTrials.gov

Recruiting

Back to Advanced Malignant Solid Tumor trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

Key details

Phase

Early testing

Sponsor

Suzhou Maximum Bio-tech Co., Ltd.

Collaborators

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Enrollment target

~18 participants

Started

May 2024

Primary completion

May 2026

Age range

18 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.